Study on the Safety for the Newborn of the Use of Biologics During Pregnancy by Mothers Affected by Autoimmune Diseases

Launched by IRCCS SAN RAFFAELE · Dec 10, 2019

Keywords

ClinConnect Summary

This clinical trial is exploring the safety of using biologic medications during pregnancy for mothers with autoimmune diseases, which are conditions where the body's immune system attacks its own cells. The study aims to understand how these medications might affect the babies born to these mothers, both right after birth and in the long term. By demonstrating that these treatments are safe for newborns, the research could help more women with autoimmune diseases access effective care during their pregnancies.

To participate in this study, children who were born to mothers treated with biologic agents are eligible. There are no specific exclusions mentioned, making it easier for families to consider joining. If you decide to participate, you and your child will help researchers gather important information that could benefit many future pregnancies. Overall, this study is crucial for understanding the impacts of these medications on newborns and ensuring safe treatment options for mothers and their children.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • children born from mothers treated with biologic agents
• Exclusion Criteria:
• • -